Investment Summary |
|
---|---|
Date | 2021-11-18 |
Target | Alliance Pharma |
Sector | Life Science |
Investor(s) | Ampersand Capital Partners |
Deal Type | Growth Capital |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Growth Capital Firm |
---|---|
Founded | 1988 |
PE ASSETS | 2.0B USD |
Size | Large |
Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 65 of 79 |
Sector (Life Science) | 31 of 39 |
Type (Growth Capital) | 19 of 26 |
State (Pennsylvania) | 1 of 1 |
Country (United States) | 57 of 65 |
Year (2021) | 8 of 8 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-11-17 |
Leinco
St. Louis, Missouri, United States Leinco is a biotechnology company that is engaged in the manufacturer of early discovery research products including antibodies, recombinant proteins, ELISA kits, second step reagents, and other life sciences products. Leinco was founded in 1992 and is based in St. Louis, Missouri. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-01-07 |
AnaBios
San Diego, California, United States AnaBios is a preclinical contract research organization (CRO) that focuses on translational research with unique capabilities to measure drug activity directly in human tissue. AnaBios is based in San Diego, California. |
Buy | - |